buyWeak

Michael Gerard Campbell bought $708 of CMRA

EVP & CFO at Comera Life Sciences Holdings, Inc.. 10,000 shares at an average of $0.07, traded Nov 27, 2023, filed Nov 28, 2023.

Conviction score

Value

$708

10,000 shares

Holdings after

35,000

+40% from before

From 52-week low

no price yet

From 52-week high

no price yet

Score components

Role
CFO
+22
Trade size
$708 at market
0
Relative to holdings
Holdings up 40%
+6
Price context
No price history yet
0
Cluster
No other insider buying within 14 days
0
Repeat buying
First buy in 90 days
0
Track record
Too few past buys to judge (0 with prices)
0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CMRAOct 9, 2026 · close 0.00

Since filing Sep 13, 2024: -99.5%SPY +77.4% · excess -176.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001062993-23-021522, as filed. Open on EDGAR

Date	Transaction	Shares	Price	Value	Holdings after	Filed
Nov 27, 2023	POpen-market purchase Common Stock	+10,000	$0.07	$708	35,000	Nov 28, 2023

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.